Skip to content

Effect of Combination Dexmedetomidine Added to Fentanyl-based Intravenous Patient-controlled Analgesia on Nausea Vomiting in Highly Susceptible Patients Undergoing Lumbar Spinal Surgery: Prospective Double Blinded Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01840254
Enrollment
108
Registered
2013-04-25
Start date
2012-09-30
Completion date
2013-09-30
Last updated
2014-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PONV

Keywords

PONV, IV PCA, dexmedetomidine, Female, non-smoking, lumbar spine surgery

Brief summary

The aim of this study is to test the hypothesis that addition of dexmedetomidine to fentanyl-based intravenous patient controlled analgesia (PCA) reduces requirement of fentanyl bolus and consequent postoperative nausea and vomiting in high-risk patients undergoing lumbar spine surgery.

Interventions

DRUGdexmedetomidine
DRUGnormal saline

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1\. female, non-smoking patient who are 20-65 of age scheduled for elective lumbar spine surgery

Exclusion criteria

1. Bradycardia on EKG (45bpm) 2. Atrioventricular conduction disorder 3. Uncontrolled hypertension 4. angina history 5. obesity (BMI ≥ 30 kg/m2) 6. Preoperative administration of opioid 7. Preoperative administration of antiemetics 8. Gastrointestinal disorder history 9. Hepatic or renal disease 10. Pregnant 11. Foreigner

Design outcomes

Primary

MeasureTime frameDescription
total dose and bolus administration of opioidan expected average of 48 hrs for requirements of total dose and number of bolus administration of PCAAfter induction of anesthesia, peak velocity of carotid artery blood flow is measured by the pulsed wave Doppler signal obtained from the left common carotid artery. Respirophasic variation of the peak velocity is defined as the difference between the maximum and the minimum values of peak velocity divided by the mean of the two values during one respiratory cycle. Fluid responder is defined as a patient whose stroke volume index is increased ≥15% after volume expansion. The receiver operating characteristic curve analysis to discriminiate fludi responder is performed.

Secondary

MeasureTime frameDescription
consequent postoperative nausea and vomitingan expected average of 48 hrs for assessing of the 11-points verbal numerical rating scalesAfter induction of anesthesia, peak velocity of carotid artery blood flow is measured by the pulsed wave Doppler signal obtained from the left common carotid artery. Respirophasic variation of the peak velocity is defined as the difference between the maximum and the minimum values of peak velocity divided by the mean of the two values during one respiratory cycle. Fluid responder is defined as a patient whose stroke volume index is increased ≥15% after volume expansion. The receiver operating characteristic curve analysis to discriminate fluid responder is performed.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026